Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
testosterone
Pharma
Clarus' fate in limbo as lead drug Jatenzo sputters
Some two years after braving the pandemic to launch its oral testosterone replacement tablet Jatenzo, Clarus Therapeutics is in dire straits.
Fraiser Kansteiner
Aug 19, 2022 10:35am
Antares, Lipocine win FDA nod for oral testosterone med
Mar 29, 2022 11:42am
After dropping case, FTC urges for new legislation
Aug 2, 2021 10:54am
Drugmakers blaze a path for new therapy launches during COVID-19
Jun 18, 2020 11:00am
Antares wins FDA nod for testosterone drug Xyosted
Oct 1, 2018 11:27am
AbbVie nears settlement covering 4,000-plus AndroGel cases
Sep 11, 2018 10:35am
